Cargando…
Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery
PURPOSE: Patients who undergo bariatric surgery are at risk for developing cholesterol gallstones. We aimed to identify risk factors that are associated with symptomatic gallstone disease and gallstone formation after bariatric surgery. MATERIALS AND METHODS: We included participants of the UPGRADE...
Autores principales: | Haal, Sylke, Guman, Maimoena S. S., Bruin, Sjoerd, Schouten, Ruben, van Veen, Ruben N., Fockens, Paul, Dijkgraaf, Marcel G. W., Hutten, Barbara A., Gerdes, Victor E. A., Voermans, Rogier P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933359/ https://www.ncbi.nlm.nih.gov/pubmed/35143012 http://dx.doi.org/10.1007/s11695-022-05947-8 |
Ejemplares similares
-
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial)
por: Haal, Sylke, et al.
Publicado: (2020) -
Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery
por: Haal, Sylke, et al.
Publicado: (2022) -
Gallstone Formation Follows a Different Trajectory in Bariatric Patients Compared to Nonbariatric Patients
por: Haal, Sylke, et al.
Publicado: (2021) -
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)
por: Boerlage, Thomas C. C., et al.
Publicado: (2017) -
Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers
por: Guman, Maimoena S. S., et al.
Publicado: (2023)